Search - tctmd.com

Displaying 481 - 500 of 891

Sort: Relevancy | Date

Presentation TCT 2013

Case Examples(9)

Presenter: Ardawan Rastan

October 28, 2013

Presentation TCT 2013

Case Examples(6)

Presenter: Ted Feldman

October 28, 2013

Presentation TCT 2013

Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives

Presenter: George Dangas

October 28, 2013

Presentation TCT 2013

And Should Also Be Based on Hemodynamic Assessments: The Dimensionless AR Index

Presenter: Jan Kovac

October 28, 2013

Presentation TCT 2013

A Review of New Aortic Valvuloplasty Systems: interValve, Loma Vista, Cardiosculpt, and PiR2

Presenter: Martin Leon

October 28, 2013

Presentation TCT 2013

A Preview of the Extreme Risk US CoreValve Registry

Presenter: Jeffrey Popma

October 28, 2013

Presentation TCT 2013

When Do I Prefer Transcarotid Vascular Access for TAVR?

Presenter: Vinod Thourani

October 28, 2013

Presentation TCT 2013

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Presenter: Anita Asgar

October 28, 2013

Presentation TCT 2013

Transcaval Access for TAVR: An Exciting New Alternative in Selected Patients

Presenter: Adam Greenbaum

October 28, 2013

Presentation TCT 2013

Transcatheter Based Aortic Valve Replacement using Tissue Engineered Heart Valves: Preclinical Experiences

Presenter: Simon Hoerstrup

October 28, 2013

Presentation TCT 2013

The Venus TAVR System (China)

Presenter: Horst Sievert

October 28, 2013

Presentation TCT 2013

The Valve Medical TAVR System (Israel)

Presenter: Martin Leon

October 28, 2013

Presentation TCT 2013

The Trinity Transapical TAVR System

Presenter: Oliver Husser

October 28, 2013

Presentation TCT 2013

The High Frequency and Insidious Consequences of Bleeding Events After TAVR (and Surgical AVR)

Presenter: Philippe Généreux

October 28, 2013

Presentation TCT 2013

The Colibri TAVR System

Presenter: Bernard Chevalier

October 28, 2013

Presentation TCT 2013

The Case for a Hybrid OR-Cath Lab for TAVR Procedures

Presenter: Alan Lumsden

October 28, 2013

Presentation TCT 2013

Technology Review and Clinical Results(4)

Presenter: Ganesh Manoharan

October 28, 2013

Presentation TCT 2013

Technology Review and Clinical Results(3)

Presenter: Karl-Heinz Kuck

October 28, 2013

Presentation TCT 2013

Technology Review and Clinical Results (REPRISE I and II Trials)

Presenter: Ian Meredith

October 28, 2013

Presentation TCT 2013

Technology Review and Clinical Results (JUPITER Registry and AR Results)

Presenter: Stephan Ensminger

October 28, 2013

Advertisement

Case Examples(9)

Case Examples(6)

Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives

And Should Also Be Based on Hemodynamic Assessments: The Dimensionless AR Index

A Review of New Aortic Valvuloplasty Systems: interValve, Loma Vista, Cardiosculpt, and PiR2

A Preview of the Extreme Risk US CoreValve Registry

When Do I Prefer Transcarotid Vascular Access for TAVR?

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Transcaval Access for TAVR: An Exciting New Alternative in Selected Patients

Transcatheter Based Aortic Valve Replacement using Tissue Engineered Heart Valves: Preclinical Experiences

The Venus TAVR System (China)

The Valve Medical TAVR System (Israel)

The Trinity Transapical TAVR System

The High Frequency and Insidious Consequences of Bleeding Events After TAVR (and Surgical AVR)

The Colibri TAVR System

The Case for a Hybrid OR-Cath Lab for TAVR Procedures

Technology Review and Clinical Results(4)

Technology Review and Clinical Results(3)

Technology Review and Clinical Results (REPRISE I and II Trials)

Technology Review and Clinical Results (JUPITER Registry and AR Results)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content